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Introduction
Reactive oxygen species (ROS) are known to have many
roles in the propagation of the inflammatory process.
Indeed increased leucocyte ROS have been implicated in
a number of autoinflammatory diseases (TRAPS, FMF,
CAPS and FCAS2).
Objective
To use genetic mapping, next generation sequencing
and functional studies to identify the genetic cause for a
severe unclassified autoinflammatory disease mimicking
Wegener’s granulomatosis in a consanguineous family.
Patients and methods
Three affected children in a Pakistani family suffered from
a severe and unusual autoinflammatory syndrome, pre-
senting in the first year of life with recurrent fevers,
erythema nodosum-like rash, severe oromucocutaneous
ulceration, systemic inflammation, and massively elevated
serum IgD, without mutation in MVK. One of the affected
children also suffered from multifocal sterile osteomyelitis
with bony lytic lesions and died at age 12 months from
bronchopneumonia, and acute cervical myelopathy from
cervical vertebral collapse. The two older children were
resistant to treatment with corticosteroids, colchicine, sev-
eral different DMARDs, anakinra and infliximab. Both
were cured by allogeneic haematopoietic stem cell trans-
plantation (HSCT) in their teenage years and remain well
and off all treatment approximately 6 years later. We
performed homozygosity mapping in the three affected
siblings, two unaffected siblings and their unaffected par-
ents; followed by targeted capture and re-sequencing of an
identified region of homozygosity. To study protein func-
tion, we used small interfering and short hairpin RNA
knockdowns in THP1 cells. THP1 cell lines were also
generated over-expressing wild-type and mutant protein
harbouring the same missense variation identified in the
patients. ROS levels were measured by flow cytometry
and production by electron spin resonance (ESR).
Co-localisation studies were conducted in HEK-293T
cells and peripheral blood mononuclear cells using con-
focal microscopy.
Results
Within the 5Mb region identified from the homozygos-
ity mapping; a missense variant of interest in a mito-
chondrial chaperone-like protein was discovered. This
segregated with disease in the family. This variant was
rare or absent in ethnically matched and other healthy
controls. Knockdown of this gene in macrophage-like
THP1 cells led to increased mitochondrial ROS produc-
tion; whilst wild-type protein overexpression led to
reduced levels of mitochondrial ROS, which was not
observed with mutant protein overexpression.
Conclusion
We describe a novel monogenic autoinflammatory disease
caused by a loss-of-function mutation in a mitochondrial
chaperone protein, leading to dysregulated mitochondrial
ROS production and severe autoinflammatory phenotype,
and cured with allogeneic HSCT.
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